Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Myeloid, Acute

Explore clinical trials studying Leukemia, Myeloid, Acute. Study availability and eligibility vary by location and protocol.

134 public trials 22 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Myeloid, Acute trial results

Active, not recruiting

A Study of Bleximenib in Combination With Acute Myeloid Leukemia (AML) Directed Therapies

NCT05453903

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +4 more
Locations
  • The University of Alabama at Birmingham Birmingham, Alabama, United States
  • City of Hope Duarte, California, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Albert Einstein College Of Medicine New York, United States
View all 32 locations
View Trial Details
Active, not recruiting

A Study of JNJ-89853413 for Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Neoplasms

NCT06618001

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +5 more
Locations
  • Arthur J E Child Comprehensive Cancer Centre Calgary, Alberta, Canada
  • Vancouver General Hospital Vancouver, British Columbia, Canada
  • Princess Margaret Hospital Toronto, Ontario, Canada
  • Hosp Clinic de Barcelona Barcelona, Spain
View Trial Details
Active, not recruiting

Study of AG-120 (Ivosidenib) vs. Placebo in Combination With Azacitidine in Participants With Previously Untreated Acute Myeloid Leukemia With an IDH1 Mutation

NCT03173248

Conditions
AML Arising From Myelodysplastic Syndrome (MDS), Hematologic Diseases, Hemic and Lymphatic Diseases, +7 more
Locations
  • Norton Cancer Institute - Suburban Louisville, Kentucky, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Royal Prince Alfred Hospital Camperdown, New South Wales, Australia
  • Royal Adelaide Hospital Adelaide, South Australia, Australia
View all 90 locations
View Trial Details
Active, not recruiting

Study to Compare Azacitidine Plus Pevonedistat Versus Azacitidine in Patients With Acute Myeloid Leukemia Not Eligible for Standard Chemotherapy

NCT04090736

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +4 more
Locations
  • Complejo Hospitalario Universitario de Santiago Santiago de Compostela, A Coruña, Spain
  • Hospital Txagorritxu Vitoria-Gasteiz, Alava, Spain
  • ICO Badalona- Hospital Universitari Germans Trias i Pujol Badalona, Barcelona, Spain
  • ICO Hospitalet- Hospital Duran i Reynals Hospitalet Del Llobregat, Barcelona, Spain
View all 62 locations
View Trial Details
Active, not recruiting

Cusatuzumab in Combination With Background Therapy for the Treatment of Participants With Acute Myeloid Leukemia

NCT04150887

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +4 more
Locations
  • City of Hope Duarte, California, United States
  • Norton Cancer Institute Louisville, Kentucky, United States
  • Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
View all 23 locations
View Trial Details
Active, not recruiting

A Study Comparing Venetoclax and Azacitidine Plus Cusatuzumab to Venetoclax and Azacitidine in Newly Diagnosed AML Ineligible for Intensive Therapy

NCT06384261

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +4 more
Locations
  • Banner MD Anderson Gilbert, Arizona, United States
  • City of Hope Duarte, California, United States
  • University of California Los Angeles Los Angeles, California, United States
  • University of Colorado Health - Anschutz Cancer Pavilion - Anschutz Medical Campus Aurora, Colorado, United States
View all 38 locations
View Trial Details
Active, not recruiting

An Efficacy and Safety Study of Oral Azacitidine (CC-486) as Maintenance Therapy in Chinese Participants With Acute Myeloid Leukemia in Complete Remission

NCT05413018

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +4 more
Locations
  • Local Institution - 0031 Hefei, Anhui, China
  • Local Institution - 0013 Beijing, BJ, China
  • Local Institution - 0027 Beijing, BJ, China
  • Local Institution - 0028 Chongqing, CQ, China
View all 34 locations
View Trial Details
Active, not recruiting

A Study to Assess the Safety and Efficacy of Two Combinations of Isocitrate Dehydrogenase (IDH) Mutant Targeted Therapies Plus Azacitidine in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) Harboring IDH Mutations Who Are Not Candidates to Receive Intensive Induction Chemotherapy

NCT02677922

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +4 more
Locations
  • Local Institution - 105 Duarte, California, United States
  • Local Institution - 107 New Haven, Connecticut, United States
  • Local Institution - 108 Chicago, Illinois, United States
  • Local Institution - 103 Chicago, Illinois, United States
View all 49 locations
View Trial Details
Active, not recruiting

A Study of Cusatuzumab Plus Azacitidine in Participants With Newly Diagnosed Acute Myeloid Leukemia Who Are Not Candidates for Intensive Chemotherapy

NCT04023526

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +4 more
Locations
  • St Vincents Hospital Sydney Darlinghurst, Australia
  • St Vincents Hospital Melbourne Fitzroy, Australia
  • The Alfred Hospital Melbourne, Australia
  • Royal Perth Hospital Perth, Australia
View all 56 locations
View Trial Details

Related conditions